ArticleActa pharmaceutica Sinica. B2021

Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice.

Lili Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.